newsfilter
← Latest News
ACCESS Newswire·

NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. today reported that it has received approval to Start Phase II Clinical Trial of NV-387 for the